{"id":"W4400850096","doi":"10.1007/s40744-024-00694-x","title":"Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study","year":2024,"lang":"en","type":"article","venue":"Rheumatology and Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Clinical Research Institute","funders":"AbbVie","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Adverse effect; Discontinuation; Safety profile; Refractory (planetary science); Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001440023,0.0005182656,0.001350396,0.0002702799,0.0002479099,0.000514646,0.0002873577,0.0005638709,0.001575406],"category_scores_gemma":[0.001035772,0.0002011445,0.001133459,0.0003303328,0.0003367291,0.0005044297,0.0002336265,0.0008449032,0.0003304339],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004800837,"about_ca_system_score_gemma":0.0005958865,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005431483,"about_ca_topic_score_gemma":0.00192956,"domain_scores_codex":[0.9996191,0.0001473387,0.00003905279,0.0000628339,0.00006742623,0.00006411328],"domain_scores_gemma":[0.999025,0.0001762645,0.0003359531,0.00008271913,0.00007796835,0.0003020709],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7924657,0.01772208,0.0625314,0.0006402059,0.001670989,0.0003591817,0.0002406154,0.001479986,0.02317728,0.00008506959,0.002209004,0.09741855],"study_design_scores_gemma":[0.2657557,0.4410259,0.2743998,0.00009885733,0.002015389,0.001084103,0.0001484357,0.002030248,0.008977836,0.0001786169,0.004184097,0.0001010497],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980844,0.0007274487,0.00008551693,0.00005083762,0.000009189098,0.0001720172,0.0004602421,0.00001523676,0.0003951466],"genre_scores_gemma":[0.9976951,0.0004169526,0.0002047891,0.0001375471,0.0000383418,0.000169717,0.000832059,0.000004984323,0.0005004266],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001575406,"threshold_uncertainty_score":0.007615626,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01572974115418642,"score_gpt":0.2788372937202226,"score_spread":0.2631075525660362,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}